September 26, 2013
The Federal Circuit ruled Thursday that Dr. Reddy's Laboratories Inc.'s planned generic version of Sunovion Pharmaceuticals Inc.'s sleep aid Lunesta infringes Sunovion's patent, reversing a lower court and deriding Dr. Reddy's "unconventional" promise that its version doesn't infringe.